PubMed:32178765 / 0-206 JSONTXT

Annnotations TAB JSON ListView MergeView

    Inflammaging

    {"project":"Inflammaging","denotations":[{"id":"T1","span":{"begin":0,"end":206},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":206},"obj":"Sentence"}],"text":"Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial."}

    yaoziqian_800_3

    {"project":"yaoziqian_800_3","denotations":[{"id":"T1","span":{"begin":0,"end":10},"obj":"CI"},{"id":"T2","span":{"begin":35,"end":54},"obj":"DP"},{"id":"T25","span":{"begin":173,"end":180},"obj":"CI"}],"text":"Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial."}

    Zierdiyeerkenaili_800_3

    {"project":"Zierdiyeerkenaili_800_3","denotations":[{"id":"T1","span":{"begin":0,"end":10},"obj":"CI"},{"id":"T5","span":{"begin":35,"end":54},"obj":"DP"},{"id":"T19","span":{"begin":173,"end":180},"obj":"CI"}],"text":"Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial."}